FDA Investigator Bing Lin
Bing Lin has inspections in 15 countries as of 08 Mar 2024. Bing Lin has collaborated with a combined 3413 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
156
Last Inspection Date:
08 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Italy,
Japan,
Taiwan,
China,
Viet Nam,
Chile,
Malaysia,
Argentina,
Thailand,
Singapore,
United Kingdom of Great Britain and Northern Ireland,
Netherlands,
France
Co-Investigator(s):
Adam C Hipko,
Adrian Rodriguez,
Akbar J Zaidi,
Alcee M Tavarez,
Amanda J White,
Andrew J Howard,
Andrew J Lang,
Angela Mock,
Angele C Smith,
Anh M Lac,
Annemarie Bodnar,
Anya D Lockett Evans,
April K Hill,
Arie R Dyk,
Ashley N Williams,
Axel M Ambert,
Betsy C Galliher,
Bevill,
Blondell W Johnson,
Bonnie L Menzel,
Brackens Harris,
Brandi E Williams,
Brandon K Barbee,
Brandon K Lawson,
Brandon O Neloms,
Brian Sanders,
Brook Shea,
Camille D Brown,
Carol A Declouette Wilburn,
Casey L Hamblin,
Cassandra L Abellard,
Castellaw,
Cathleen A Castellaw,
Chad J Whitwell,
Charles B Steinmiller,
Charles D Brown,
Cheryl G Scott,
Chmura,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher K Gibbs,
Christopher L Jacobs,
Clara E Santiago,
Coleen L Manoy,
Connie L Hannon Rabel,
Constance M Dobbins,
Crystal A Harlan,
Crystal S Harris,
Crystal S Harris Smith,
Cymbre Weatherly,
Dallas E Gilbreath Jr,
Dana M Lewis,
Daniel J Lahar,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
Debbie J Cunningham,
Debra D Devlieger,
Decarlos A Gomez,
Denise Connelly,
Deniza Karacic,
Devon Jenkins,
Dirk L Lincoln,
Ed Gonzalez Vazquez,
Edna J Hidalgo,
Elisa M Fleming,
Elizabeth D Connell,
Elizabeth P Mayer,
Elkins,
Elvia J Cervantes,
Enspect User,
Ernest Serna, III,
Fernando C Martinez,
Frans E Mercado,
Fred R Strominger,
Gale L Glinecki,
Gatica,
Glasgow,
Grant,
Grant L Davis,
Gregory A Holt,
Hala L Selby,
Haley L Coleman,
Harrisv,
Holly J Rapier,
Hudson,
Hung V Le,
Hurst,
Iris C Macinnes,
Jacey Roy,
Jacob W Reynolds,
Jamie M Bumpas,
Jane M Broussard,
Janice M Hickok,
Jason P Aun,
Jeffrey R Wooley,
Jennifer D Young,
Jennifer Owens Dowdy,
Jeremy L Stukes,
Jodi M Gatica,
Jogy George,
Johann M Fitch,
Johnson,
Jonaida Estevez Martinez,
Jonathan A Womack,
Jonathan M Mcbride,
Joshua L Gibbs,
Joy L Ramsey,
Juan D Lopez,
Judith A Jones,
Justin A Boyd,
Kamara Tx,
Kari M Johansen,
Karlton T Watson,
Kayla R Deatherage,
Keith A Schwartz,
Kenitra D Hewitt,
Khunnathee Stoner,
King,
Kristen E Szenderski,
Kristin N Longfellow,
Krystyna M Kitson,
Kunapuli T Madhusudhan,
Latorie S Jones,
Lauren E Skokan,
Lauren R Brady,
Lauren R Howell,
Lawrence C Coleman,
Leighton K Ngai,
Lisa M Puttonen,
Lisa M Yoder,
Lisa R Jennings,
Lisa R Whitt,
Liza L Quiles,
Lloyd D Payne,
Loan T Tran,
Loretta Nemchik,
Lorie S Hannappel,
Lourdes R Genera,
Luis E Gonzalez,
Maira P Brading,
Marc R Dickens,
Marcelo O Mangalindan, Jr,
Margaret M Annes,
Margarito J Uribe,
Margo C Jones,
Martha S Baldwin,
Martin K Essary,
Massoud Motamed,
Matthew S Mccollough,
Michael L Jones,
Monique Rac Lester,
Ninfa N Innocent,
Osama A Khatib,
Patrick D Stone, MS,
Paul E Frazier,
Paula J Perry,
Pauline N Logan,
Payne,
Philip M Steele, PhD,
Phillip J Sample,
Raymond L Cheung,
Raymond M Lam,
Rebecca C O Bryan,
Rebecca M Allen,
Rene R Ramirez,
Renee Johnson, RS,
Rhonda L Dash,
Rian L Pope,
Robert T Harris,
Robert T Lorenz,
Rodriguez,
Rowena Trevino Solis,
Roy Baby,
Saleem A Akhtar,
Sandy J Ziegler,
Sara A Valenzuela,
Sarah L Fredric,
Scott R Nichols, PhD,
Scott T Ballard,
Sean M Cheney,
Selina M Mata,
Seri Essary,
Seri L Essary,
Shannon A Lowe,
Shawn E Larson,
Staci G Mcallister,
State Agency,
Tamera H Hunt,
Tara A Gray,
Theresa Kirkham (NMI),
Timothy B Webb,
Toby Vern H Hill,
Torrance J Slayton,
Tracy J Washington,
Travis M Beard,
Travis S Brown,
Tricia S Martinez,
Trina K Vick,
Tuan A Nguyen,
Verlinda A Narcisse,
Yaw O Osei,
Young M Yoon
Bing Lin's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2021 | FDA 483 | Cosmax Nbt Usa, Inc. - Form 483, 2021-05-04 |
December, 2016 | FDA 483 | Kraft Heinz Company - Form 483, 2016-12-09 |
December, 2023 | FDA 483 | Mead Johnson & Company LLC - Form 483, 2023-12-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more